Shaker Dakhil is an Oncology physician affiliated with Cancer Center of Kansas. OpenAlex indexes 452 publications with 38,028 citations (h-index 81). By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
25 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
39.9%PD-1 inhibitor18.8%Pembrolizumab55%Nivolumab45%Part B, office-administered≥40 patientsPlatinum-based Drug6.3%Oxaliplatin97%Carboplatin3%Part B, office-administered≥43 patients+ 15 more classes in this area
Blood & clotting
28.1%Iron, parenteral preparations20.8%Ferric carboxymaltose100%Part B, office-administered≥41 patientsErythropoiesis-stimulating Agent7.3%Darbepoetin alfa58%Epoetin alfa42%Part B, office-administered≥26 patientsMetabolism & gastrointestinal
17.1%Substance P/Neurokinin-1 Receptor Antagonist9.5%Aprepitant100%Part B, office-administered≥103 patientsSerotonin-3 Receptor Antagonist7.1%Granisetron82%Ondansetron hydrochloride14%Palonosetron hcl4%Ondansetron Hcl0%Ondansetron Odt0%Part D + Part B≥84 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2001–2018 per NIH RePORTER. The latest:
- National Community Oncology Research Project
Via Christi Regional Medical Center
FY2018$1,527,000UG1CA189808 - National Community Oncology Research Project
Via Christi Regional Medical Center
FY2017$1,835,874UG1CA189808 - National Community Oncology Research Project
Via Christi Regional Medical Center
FY2016$1,612,500UG1CA189808
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”